InnoCan Pharma Corporation (INNO.CN)
CAD 0.19
(-7.5%)
CAD 0.19
(-7.5%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.55 Million USD | 240.08% |
| 2022 | 751 Thousand USD | -78.93% |
| 2021 | 3.56 Million USD | -55.12% |
| 2020 | 7.94 Million USD | 579.3% |
| 2019 | 1.16 Million USD | 119.32% |
| 2018 | 533 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 4.33 Million USD | 69.66% |
| 2024 Q2 | 2.67 Million USD | -38.26% |
| 2023 Q2 | 899 Thousand USD | -15.11% |
| 2023 Q4 | 2.55 Million USD | 7.9% |
| 2023 Q1 | 1.05 Million USD | 41.01% |
| 2023 FY | 2.55 Million USD | 240.08% |
| 2023 Q3 | 2.36 Million USD | 163.29% |
| 2022 Q3 | 1.05 Million USD | -54.45% |
| 2022 FY | 751 Thousand USD | -78.93% |
| 2022 Q1 | 2.54 Million USD | -28.73% |
| 2022 Q4 | 751 Thousand USD | -28.82% |
| 2022 Q2 | 2.31 Million USD | -8.82% |
| 2021 Q1 | 4.53 Million USD | -42.92% |
| 2021 FY | 3.56 Million USD | -55.12% |
| 2021 Q4 | 3.56 Million USD | 12.54% |
| 2021 Q3 | 3.16 Million USD | -21.86% |
| 2021 Q2 | 4.05 Million USD | -10.59% |
| 2020 Q2 | 2.06 Million USD | 343.56% |
| 2020 Q1 | 466 Thousand USD | -60.14% |
| 2020 FY | 7.94 Million USD | 579.3% |
| 2020 Q4 | 7.94 Million USD | 243.32% |
| 2020 Q3 | 2.31 Million USD | 11.9% |
| 2019 Q4 | 1.16 Million USD | -60.36% |
| 2019 Q1 | - USD | -100.0% |
| 2019 FY | 1.16 Million USD | 119.32% |
| 2019 Q2 | 22 Thousand USD | 0.0% |
| 2019 Q3 | 2.94 Million USD | 13304.55% |
| 2018 FY | 533 Thousand USD | 0.0% |
| 2018 Q4 | 533 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aion Therapeutic Inc. | 2.93 Million CAD | 13.026% |
| Ayurcann Holdings Corp. | 14.31 Million CAD | 82.164% |
| Blueberries Medical Corp. | 470.72 Thousand CAD | -442.57% |
| The BC Bud Corporation | 626 Thousand CAD | -307.985% |
| BioNxt Solutions Inc. | 6.55 Million CAD | 61.009% |
| CordovaCann Corp. | 11.29 Million CAD | 77.38% |
| Christina Lake Cannabis Corp. | 8.5 Million CAD | 69.956% |
| Captor Capital Corp. | 28.76 Million CAD | 91.121% |
| City View Green Holdings Inc. | 3.73 Million CAD | 31.583% |
| 1CM Inc. | 9.42 Million CAD | 72.898% |
| Global Hemp Group Inc. | 5.82 Million CAD | 56.156% |
| Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 87.938% |
| IM Cannabis Corp. | 35.11 Million CAD | 92.726% |
| Lobe Sciences Ltd. | 2.45 Million CAD | -3.837% |
| Maple Leaf Green World Inc. | 10.08 Million CAD | 74.665% |
| Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -889.923% |
| Nextleaf Solutions Ltd. | 4.4 Million CAD | 41.999% |
| Ovation Science Inc. | 728.99 Thousand CAD | -250.347% |
| Pharmadrug Inc. | 2.92 Million CAD | 12.698% |
| Captiva Verde Wellness Corp. | 2.08 Million CAD | -22.262% |
| RAMM Pharma Corp. | 2.83 Million CAD | 9.928% |
| RIV Capital Inc. | 275.63 Million CAD | 99.073% |
| Revive Therapeutics Ltd. | 3.4 Million CAD | 24.969% |
| Red White & Bloom Brands Inc. | 364.63 Million CAD | 99.3% |
| SLANG Worldwide Inc. | 37.58 Million CAD | 93.204% |
| 1933 Industries Inc. | 23.28 Million CAD | 89.031% |
| Red Light Holland Corp. | 3.82 Million CAD | 33.17% |
| Top Strike Resources Corp. | 20.99 Million CAD | 87.835% |
| Xebra Brands Ltd. | 789.95 Thousand CAD | -223.31% |
| Adastra Holdings Ltd. | 17.65 Million CAD | 85.536% |